Evidence map›Paper›PMID 16526944›Full record

ReviewThe Biochemical journal2006

Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

James Beattie, Gordon J Allan, Jennifer D Lochrie, David J Flint

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in The Biochemical journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03673202 (A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urinary Tract Urothelial Carcinoma), which is not on this map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03673202 unknown statusnot on this mapstarted 2018, after this paper: background citation

A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urinary Tract Urothelial Carcinoma

TypeobservationalSponsorLondon Health Sciences CentreRan2018 to 2020Enrolled300ConditionsBladder CancerArmsCx bladder Monitor test
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 242 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity viaInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. NADPH Oxidase 3: Beyond the Inner Ear.Antioxidants (Basel, Switzerland) · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

James BeattieHannah Research Institute, Ayr KA6 5HL, Scotland, UK. j.beattie@hannah.ac.uk
Gordon J Allan
Jennifer D Lochrie
David J Flint
Hannah Research Foundation · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The six members of the insulin-like growth factor-binding protein family (IGFBP-1-6) are important components of the IGF (insulin-like growth factor) axis. In this capacity, they serve to regulate the activity of both IGF-I and -II polypeptide growth factors. The IGFBPs are able to enhance or inhibit the activity of IGFs in a cell- and tissue-specific manner. One of these proteins, IGFBP-5, also has an important role in controlling cell survival, differentiation and apoptosis. In this review, we report on the structural and functional features of the protein which are important for these effects. We also examine the regulation of IGFBP-5 expression and comment on its potential role in tumour biology, with special reference to work with breast cancer cells.

Indexed as

AnimalsExtracellular MatrixInsulin-Like Growth Factor Binding Protein 5NeoplasmsProtein BindingProtein Processing, Post-TranslationalSomatomedinsInsulin-Like Growth Factor Binding Protein 5Somatomedins

Identifiers

PMID16526944
PMCPMC1409685
OpenAlexW1966876518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.